- Investing Ideas
- /
- Polish Pharmaceuticals & Biotech Undervalued based on future growth
Polish Pharmaceuticals & Biotech Undervalued based on future growth
Results
1
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SLV | zł48.60 | 2.9% | -16.9% | zł892.1m | zł62.15 | PE16.5x | E21.1% | n/a |
Page 1 of 1